Medical Marijuana, Inc. CEO Dr. Stuart Titus Discusses Booming Cannabis Industry on U-T Community Spotlight

by adminTorusBrand | Nov 21, 2016 | Axim Biotechnologies, Company News, Media Coverage, Scientific Research

Medical Marijuana, Inc. president and CEO featured on San Diego Union-Tribune radio show to talk about new developments in the marijuana industry. Dr. Stuart Titus, CEO of Medical Marijuana, Inc., took time away from the 5th Annual Marijuana Business Conference and...

U.S. Patent Allowance Granted to Medical Marijuana, Inc.’s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

by adminTorusBrand | Nov 16, 2016 | Axim Biotechnologies, Press Releases

SAN DIEGO, CA–(Marketwired – November 16, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its major investment AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM), a world leader in hemp cannabinoid research and development,...

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Secures Funding for Clinical Trials

by adminTorusBrand | Nov 8, 2016 | Axim Biotechnologies, Company News

Medical Marijuana, Inc. announced this week that AXIM® Biotechnologies secured the necessary private funding needed to continue its pharmaceutical clinical trials program in the development of cannabinoid medications for multiple medical indications. On news of AXIM®...

MEDICAL MARIJUANA, INC. INVESTMENT AXIM® BIOTECHNOLOGIES, INC. PUBLISHES PRODUCT PIPELINE CHART FOR PHARMA CLINICAL TRIALS PROGRAM IN CANNABINOID R&D

by adminTorusBrand | Nov 3, 2016 | Axim Biotechnologies, Media Coverage, Press Releases

Cannabinoid Innovator’s Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple Indications    NEW YORK – Nov. 3, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that...

Medical Marijuana, Inc. Portfolio Company AXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering Patients

by adminTorusBrand | Nov 1, 2016 | Axim Biotechnologies, Press Releases

NEW YORK, NY –(Marketwired – November 01, 2016) – Medical Marijuana, Inc.(MJNA) today announced that its portfolio company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has begun pharmacokinetic/pharmacodynamics (PK/PD) studies with its CanChew...